MedTrace Logo

To Study the Pharmacokinetic and Cardiovascular Effects of Propofol With Respect to Pharmacogenetics in Pakistani Population

NCT05383534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2022-05-20

No results posted yet for this study

Summary

This study aimed to determine the effects of genetic variabilities among the Pakistani population on propofol serum concentration and its adverse effects mainly cardiovascular adverse effects. cardiovascular adverse effects are the main concern for the anesthetists, if a person is genetically more prone to these adverse effects it can be lethal for that.

Conditions

  • Healthy Volunteer

Interventions

DRUG

Propofol Injection

propofol injections were used for the induction of anesthesia according to the body weight of the patients.

Sponsors & Collaborators

  • Holy Family Hospital, Rawalpindi.

    collaborator UNKNOWN

  • Riphah International University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-06
Primary Completion
2021-05-10
Completion
2022-04-14

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05383534 on ClinicalTrials.gov